Demand for Indian COVID-19 vaccines from foreign countries

 Demand for Indian COVID-19 vaccines from foreign countries
Share this post

New Delhi, March 16, 2021: Ministry of External Affairs has received several requests for the supply of Indian manufactured COVID-19 vaccines from various foreign countries.

In its Press Release of 19 January 2021, Ministry of External Affairs had stated that “Immunization programme is being implemented in India, as in other countries, in a phased manner to cover the healthcare providers, frontline workers and the most vulnerable. Keeping in view the domestic requirements of the phased rollout, India will continue to supply COVID-19 vaccines to partner countries over the coming weeks and months in a phased manner. It will be ensured that domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad.”

    S.NoCountryTotal Supplies so far (in Lakhs)
 Bangladesh90
 Myanmar37
 Nepal23.48
 Bhutan1.5
 Maldives2.12
 Mauritius2
 Seychelles0.5
 Sri Lanka12.64
 Bahrain1
 Brazil40
 Morocoo70
 Oman1
 Egypt0.5
 Algeria0.5
 South Africa10
 Kuwait2
 UAE2
 Afghanistan9.68
 Barbados1
 Dominica0.7
 Mexico8.7
 Dominican Republic0.5
 Saudi Arabia30
 El Salvador0.2
 Argentina5.8
 Serbia1.5
 UN Health workers1
 Mongolia1.5
 Ukraine5
 Ghana6.52
 Ivory Coast5.54
 St. Lucia0.25
 St. Kitts & Nevis0.2
 St. Vincent & Grenadines0.4
 Suriname0.5
 Antigua & Barbuda0.4
 DR Congo17.66
 Angola6.24
 Gambia0.36
 Nigeria39.24
 Cambodia3.24
 Kenya11.2
 Lesotho0.36
 Rwanda2.9
 Sao Tome & Principe0.24
 Senegal3.49
 Guatemala2
 Canada5
 Mali3.96
 Sudan8.28
 Liberia0.96
 Malawi3.6
 Uganda9.64
 Nicaragua2.00
 Guyana0.8
 Jamaica0.50
 UK50.00
 Togo1.56
 Djibouti0.24
 Somalia3.00
 Seirra Leone0.96
 Belize0.25
 Botswana0.30
 Mozambique4.84
 Ethiopia21.84
 Tajikistan1.92
 Benin1.44
 Eswatini0.20
 Bahamas0.20
 Cape Verde0.24
TOTAL583.85

The Minister of State (Health and Family Welfare), Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here today.

Subscribe to our newsletter!

Other related posts

error: Content is protected !!